Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis

Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis

We evaluate the feasibility of a concurrent application of sorafenib and external beam radiation therapy (EBRT) for advanced hepatocellular carcinoma (HCC). PubMed, Embase, Medline, and Cochrane Library were searched up to 9 April 2021. The primary endpoint was grade ≥3 complications, and the second...

Full description

Bibliographic Details
Main Authors: Chai Hong Rim, Sunmin Park, In-Soo Shin, Won Sup Yoon
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
sorafenib
external beam radiation therapy
concurrent
combined
hepatocellular carcinoma
toxicity
Online Access:https://www.mdpi.com/2072-6694/13/12/2912

Internet

https://www.mdpi.com/2072-6694/13/12/2912

Similar Items